← Leaderboards
Rebecca E Schweppe
University Of Colorado At Boulder
$4,544,172
Attributed
$4,544,172
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $542.4K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,544,172 · 4
By mechanism
R01$4,213,991 · 2
R25$313,725 · 1
F32$16,456 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado At Boulder
Same institution · by research overlap
- Thomas E. Johnson$13,104,639
- Christopher D Link$10,776,150
Others in their field
Top investigators on “Clinic”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,108,147,906
- Leonard Freedman · Leidos Biomedical Research, Inc.$978,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$798,941,641
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$639,436,363
- Barton F Haynes · Duke University$546,907,423
Research focus
ClinicMalignant NeoplasmsMutationNeoplasm MetastasisClinically RelevantMolecularGeneticCancer PatientGrowthMalignant Neoplasm Of ThyroidCancer ModelCessation Of LifeMap Kinase GeneMediator Of Activation ProteinBaseDistant MetastasisEffective TherapyFocal Adhesion Kinase 1ComplexCancer CellIn VivoIn VitroNovel StrategiesOncogenic
Grant awards (12)
Cancer Research Experiences for Undergraduates (CREU)$313,725
R25 · FY2024 · CA · contact PI
Targeting FAK and Src in thyroid cancer$520,597
R01 · FY2022 · CA · contact PI
Targeting FAK and Src in thyroid cancer$531,221
R01 · FY2021 · CA · contact PI
Targeting FAK and Src in thyroid cancer$532,916
R01 · FY2020 · CA · contact PI
Targeting FAK and Src in thyroid cancer$519,881
R01 · FY2019 · CA · contact PI
Targeting FAK and Src in thyroid cancer$542,360
R01 · FY2018 · CA · contact PI
Targeting Focal Adhesion Kinase in Thyroid Cancer$320,359
R01 · FY2016 · CA · contact PI
Targeting Focal Adhesion Kinase in Thyroid Cancer$320,359
R01 · FY2015 · CA · contact PI
Targeting Focal Adhesion Kinase in Thyroid Cancer$309,763
R01 · FY2014 · CA · contact PI
Targeting Focal Adhesion Kinase in Thyroid Cancer$299,226
R01 · FY2013 · CA · contact PI
Targeting Focal Adhesion Kinase in Thyroid Cancer$317,309
R01 · FY2012 · CA · contact PI
The Regulation of the MAP Kinase Pathway and DNA Repair$16,456
F32 · FY2002 · GM